| (in millions $) | 30 Aug 2020 | 30 May 2020 | ||
|---|---|---|---|---|
| Current assets | ||||
| Cash | $5.89 | $5.89 | ||
| Short term investments | ||||
| Net receivables | $12.94 | $12.94 | ||
| Inventory | ||||
| Total current assets | $23.47 | $23.47 | ||
| Long term investments | ||||
| Property, plant & equipment | $0.68 | $0.68 | ||
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $257.26 | $257.22 | ||
| Total investments | ||||
| Total assets | $37.38 | $37.38 | ||
| Current liabilities | ||||
| Accounts payable | $0.01 | $0.01 | ||
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $4.02 | $4.02 | ||
| Long term debt | ||||
| Total noncurrent liabilities | $251.21 | $251.66 | ||
| Total debt | ||||
| Total liabilities | $6.81 | $6.81 | ||
| Shareholders' equity | ||||
| Retained earnings | $25.58 | $25.58 | ||
| Other shareholder equity | ||||
| Total shareholder equity | $30.58 | $30.58 | ||
| (in millions $) | 28 Feb 2020 | 27 Feb 2019 | ||
|---|---|---|---|---|
| Current assets | ||||
| Cash | $0.17 | $0 | ||
| Short term investments | ||||
| Net receivables | $13.4 | |||
| Inventory | ||||
| Total current assets | $18.95 | $3.2 | ||
| Long term investments | ||||
| Property, plant & equipment | $0 | $0 | ||
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $255.08 | |||
| Total investments | ||||
| Total assets | $19.24 | $3.2 | ||
| Current liabilities | ||||
| Accounts payable | ||||
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $2.87 | $5.41 | ||
| Long term debt | ||||
| Total noncurrent liabilities | $250.37 | |||
| Total debt | ||||
| Total liabilities | $2.87 | $5.41 | ||
| Shareholders' equity | ||||
| Retained earnings | $11.37 | -$2.21 | ||
| Other shareholder equity | ||||
| Total shareholder equity | $16.37 | -$2.21 | ||
| (in millions $) | 30 Aug 2020 | 30 May 2020 | ||
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $11.85 | $11.85 | ||
| Cost of revenue | $1.28 | $1.28 | ||
| Gross Profit | $10.56 | $10.56 | ||
| Operating activities | ||||
| Research & development | $0.01 | $0.01 | ||
| Selling, general & administrative | $1.91 | $1.91 | ||
| Total operating expenses | $3.2 | $3.2 | ||
| Operating income | $8.65 | $8.65 | ||
| Income from continuing operations | ||||
| EBIT | $8.65 | $8.65 | ||
| Income tax expense | $1.51 | $1.51 | ||
| Interest expense | -$0.04 | -$0.04 | ||
| Net income | ||||
| Net income | $7.1 | $7.1 | ||
| Income (for common shares) | $7.1 | $7.1 | ||
| (in millions $) | 28 Feb 2020 | 27 Feb 2019 | ||
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $16.9 | |||
| Cost of revenue | $0.1 | |||
| Gross Profit | $16.79 | |||
| Operating activities | ||||
| Research & development | $0.01 | $0.74 | ||
| Selling, general & administrative | $1.43 | $1.15 | ||
| Total operating expenses | $1.72 | $1.89 | ||
| Operating income | $15.17 | -$1.89 | ||
| Income from continuing operations | ||||
| EBIT | $15.17 | -$1.89 | ||
| Income tax expense | $1.59 | |||
| Interest expense | -$0 | -$0 | ||
| Net income | ||||
| Net income | $13.58 | -$1.9 | ||
| Income (for common shares) | $13.58 | -$1.9 | ||
| (in millions $) | 30 Aug 2020 | 30 May 2020 | ||
|---|---|---|---|---|
| Net income | $7.1 | $7.1 | ||
| Operating activities | ||||
| Depreciation | $0.01 | $0.01 | ||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $6.6 | $6.6 | ||
| Investing activities | ||||
| Capital expenditures | -$0 | -$0 | ||
| Investments | ||||
| Total cash flows from investing | -$3.73 | -$3.73 | ||
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | -$0.01 | -$0.01 | ||
| Total cash flows from financing | -$0.01 | -$0.01 | ||
| Effect of exchange rate | ||||
| Change in cash and equivalents | $2.86 | $2.86 | ||
| (in millions $) | 28 Feb 2020 | 27 Feb 2019 | ||
|---|---|---|---|---|
| Net income | $13.58 | -$1.9 | ||
| Operating activities | ||||
| Depreciation | $0 | $0 | ||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $0.29 | -$4.29 | ||
| Investing activities | ||||
| Capital expenditures | -$0 | |||
| Investments | ||||
| Total cash flows from investing | -$0.12 | -$0 | ||
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | -$5.01 | $4.29 | ||
| Total cash flows from financing | -$0.01 | $4.29 | ||
| Effect of exchange rate | ||||
| Change in cash and equivalents | $0.16 | $0 | ||
|
Novavax Stock Gains Ahead of EU Covid Vaccine Approval
TheStreet.com
20 Dec 2021
|
|
56 Biggest Movers From Yesterday
Benzinga
10 Dec 2021
|
|
21 Stocks Moving in Thursday's Pre-Market Session
Benzinga
9 Dec 2021
|
|
Why You Should Retain Global Payments (GPN) Stock for Now
Zacks via Yahoo Finance
7 Dec 2021
|
|
61 Biggest Movers From Yesterday
Benzinga
2 Dec 2021
|
|
Here's Why Triterras, Inc. (TRIT) Could be Great Choice for a Bottom Fisher
Zacks via Yahoo Finance
30 Nov 2021
|
|
Triterras (TRIT) Sees Hammer Chart Pattern: Time to Buy?
Zacks via Yahoo Finance
30 Nov 2021
|
|
66 Biggest Movers From Yesterday
Benzinga via Yahoo Finance
29 Oct 2021
|
|
48 Stocks Moving In Thursday's Mid-Day Session
Benzinga via Yahoo Finance
28 Oct 2021
|
|
Should I Avoid Triterras, Inc. (TRIT)?
Insider Monkey via Yahoo Finance
4 Oct 2021
|
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 32.31M |
| Revenue | $23.69M |
|---|---|
| EBITDA | $17.31M |
| EBIT | $17.30M |
| Net Income | $14.21M |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | 0.00 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | 0.18 |
| EPS | $0.44 |
|---|---|
| ROA | 76.01% |
| ROE | 92.93% |
| Debt/Equity | 0.18 |
|---|---|
| Net debt/EBITDA | 0.05 |
| Current ratio | 5.84 |
| Quick ratio | N/A |